Warfvinges väg 35
BioArctic AB is a Swedish privately held research-based biopharmaceutical company founded in 2003. The company’s mission is to provide new and effective treatments for patients with disorders in the central nervous system. Its proprietary technology and dedicated personnel have made it possible to develop new immunotherapeutic approaches to neurodegenerative diseases. We focus on therapy areas with a large medical need such as Alzheimer’s disease, Parkinson’s disease and spinal cord injury.
CEO: Gunilla Osswald
CSO: Christer Möller
CMO: Hans Basun
Please click here for BioArctic job opportunities.
Please click here for clinical trial information.